Research output per year
Research output per year
Search results
-
2022
Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)
Ghorbanalipoor, S., Emtenani, S., Parker, M., Kamaguchi, M., Osterloh, C., Pigors, M., Gross, N., Khil’chenko, S., Kasprick, A., Patzelt, S., Wortmann, D., Ibrahim, I. O., Izumi, K., Goletz, S., Boch, K., Kalies, K., Bieber, K., Smith, P., Schmidt, E. & Ludwig, R. J., 30.11.2022, In: Frontiers in Immunology. 13, 1099535.Research output: Journal Articles › Comments/Debates
2 Citations (Scopus) -
Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
Boch, K., Langan, E. A., van Beek, N., Kridin, K., Schmidt, E., Zillikens, D., Ludwig, R. J., Hammers, C. M. & Bieber, K., 2022, In: Acta Dermato-Venereologica. 102, adv00835.Research output: Journal Articles › Comments/Debates
-
Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
Boch, K., Langan, E. A., Schmidt, E., Zillikens, D., Ludwig, R. J., Bieber, K. & Hammers, C. M., 25.03.2022, In: Acta Dermato-Venereologica. 102, adv00679.Research output: Journal Articles › Comments/Debates